Healthcare >> CEO Interviews >> July 31, 2014
Kim D. Blickenstaff has served as Tandem Diabetes Care, Inc.’s President and Chief Executive Officer, and as a director since September 2007. Prior to joining Tandem, Mr. Blickenstaff served as Chairman and Chief Executive Officer of Biosite Incorporated, a provider of medical diagnostic products, from 1988 until its acquisition by Inverness Medical Innovations, Inc., in June 2007. Mr. Blickenstaff currently serves as Chairman of Medivation, Inc. (MDVN), and is a member of its audit committee and compensation committee. He previously served as a director of Dexcom, Inc. (DXCM), a provider of glucose monitoring systems, from June 2001 to September 2007. Mr. Blickenstaff was formerly a certified public accountant and has more than 20 years of experience overseeing the preparation of financial statements. He received a B.A. in political science from Loyola University, Chicago, and an MBA from the Graduate School of Business, Loyola University, Chicago. Profile
Mr. Blickenstaff: Tandem Diabetes Care is a medical device company with an innovative, user-centric
